BiomeSense
Kevin is a skilled STEM commercialization leader with more than eight years’ experience in the healthcare space. Prior to joining BiomeSense, Kevin provided strategic and operational leadership as the Director of Operations for a seed-stage pharmacogenomics spinoff from the University of Chicago.
BiomeSense
BiomeSense is revolutionizing human microbiome research by creating novel tools to track, analyze, and store daily microbiome profiles of clinical trial participants, providing vastly more data than is possible with current tools, all for a fraction of the cost. This gives investigators far deeper insight into how the microbiome influences and is influenced by clinical interventions.